Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 2/2024

05.02.2024 | Clinical Investigation

Levofloxacin susceptibility of Staphylococci from conjunctiva in patients with atopic dermatitis

verfasst von: Yumi Kusumi, Yoshimasa Ando, Chika Shigeyasu, Masaki Fukui, Masakazu Yamada

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The ocular surface in patients with atopic dermatitis (AD) is known to harbor an abundance of gram-positive cocci, particularly Staphylococcus aureus (S. aureus). This study reviewed the results of microbial cultures from the conjunctiva in AD patients, with special attention to the levofloxacin susceptibility of Staphylococci.

Study design

Retrospective, single-center study.

Methods

This study involved 131 eyes of 112 Japanese patients with AD (87 men and 25 women, mean age: 40.4 ± 12.2 years) who underwent ocular surgery at Kyorin University Hospital. Bacterial isolates were collected from the conjunctival sacs in the preoperative period. Drug resistance to methicillin and levofloxacin was judged using the minimal inhibitory concentrations of oxacillin and levofloxacin determined by the broth dilution method.

Results

One hundred and fifty-seven strains were identified in 103 of the 131 eyes examined. S. aureus was isolated from 74 eyes (56.5%), followed by Staphylococcus epidermidis (S. epidermidis). In S. aureus, 11 strains (14.9%) were methicillin-resistant, and 18 (24.3%) were levofloxacin-resistant. In S. epidermidis, 15 strains (26.8%) were methicillin-resistant, and 17 (30.4%) were levofloxacin-resistant. No significant differences were observed in levofloxacin susceptibility with age, sex, previous ocular surgery, or duration of previous surgery. However, logistic multivariate analysis revealed that levofloxacin-resistant Staphylococci were concurrently resistant to methicillin, suggesting multidrug resistance.

Conclusion

Distinctive bacterial distribution and drug resistance need consideration in the managing of ocular disorders among patients with AD.
Literatur
1.
Zurück zum Zitat Bercovitch L. Screening for ocular complications in atopic dermatitis. Arch Dermatol. 2011;147:588–9.CrossRefPubMed Bercovitch L. Screening for ocular complications in atopic dermatitis. Arch Dermatol. 2011;147:588–9.CrossRefPubMed
2.
Zurück zum Zitat Hsu JI, Pflugfelder SC, Kim SJ. Ocular complications of atopic dermatitis. Cutis. 2019;104:189–93.PubMed Hsu JI, Pflugfelder SC, Kim SJ. Ocular complications of atopic dermatitis. Cutis. 2019;104:189–93.PubMed
3.
Zurück zum Zitat Yura A, Kouda K, Iki M, Shimizu T. Trends of allergic symptoms in school children: large-scale long-term consecutive cross-sectional studies in Osaka Prefecture, Japan. Pediatr Allergy Immunol. 2011;22:631–7.CrossRefPubMed Yura A, Kouda K, Iki M, Shimizu T. Trends of allergic symptoms in school children: large-scale long-term consecutive cross-sectional studies in Osaka Prefecture, Japan. Pediatr Allergy Immunol. 2011;22:631–7.CrossRefPubMed
5.
Zurück zum Zitat Hida T, Tano Y, Okinami S, Ogino N, Inoue M. Multicenter retrospective study of retinal detachment associated with atopic dermatitis. Jpn J Ophthalmol. 2000;44:407–18.CrossRefPubMed Hida T, Tano Y, Okinami S, Ogino N, Inoue M. Multicenter retrospective study of retinal detachment associated with atopic dermatitis. Jpn J Ophthalmol. 2000;44:407–18.CrossRefPubMed
6.
Zurück zum Zitat Choi M, Byun SJ, Lee DH, Kim KH, Park KH, Park SJ. The association with rhegmatogenous retinal detachment and paediatric atopic dermatitis: a 12-year nationwide cohort study. Eye. 2020;34:1909–15.CrossRefPubMedPubMedCentral Choi M, Byun SJ, Lee DH, Kim KH, Park KH, Park SJ. The association with rhegmatogenous retinal detachment and paediatric atopic dermatitis: a 12-year nationwide cohort study. Eye. 2020;34:1909–15.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38:265–9.CrossRefPubMed Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38:265–9.CrossRefPubMed
8.
Zurück zum Zitat Edslev SM, Agner T, Andersen PS. Skin microbiome in atopic dermatitis. Acta Derm Venereol. 2020;100:adv00164.CrossRefPubMed Edslev SM, Agner T, Andersen PS. Skin microbiome in atopic dermatitis. Acta Derm Venereol. 2020;100:adv00164.CrossRefPubMed
9.
Zurück zum Zitat Jagadeesan S, Kurien G, Divakaran MV, Sadanandan SM, Sobhanakumari K, Sarin A. Methicillin-resistant Staphylococcus aureus colonization and disease severity in atopic dermatitis: a cross-sectional study from South India. Indian J Dermatol Venereol Leprol. 2014;80:229–34.CrossRefPubMed Jagadeesan S, Kurien G, Divakaran MV, Sadanandan SM, Sobhanakumari K, Sarin A. Methicillin-resistant Staphylococcus aureus colonization and disease severity in atopic dermatitis: a cross-sectional study from South India. Indian J Dermatol Venereol Leprol. 2014;80:229–34.CrossRefPubMed
10.
Zurück zum Zitat Nakata K, Inoue Y, Harada J, Maeda N, Watanabe H, Tano Y, et al. A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis. Ophthalmology. 2000;107:2167–71.CrossRefPubMed Nakata K, Inoue Y, Harada J, Maeda N, Watanabe H, Tano Y, et al. A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis. Ophthalmology. 2000;107:2167–71.CrossRefPubMed
11.
Zurück zum Zitat Nivenius E, Montan PG, Chryssanthouw E, Jungw K, van Hage-Hamstenz M, van der Ploeg I. No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis. Clin Exp Allergy. 2004;34:725–30.CrossRefPubMed Nivenius E, Montan PG, Chryssanthouw E, Jungw K, van Hage-Hamstenz M, van der Ploeg I. No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis. Clin Exp Allergy. 2004;34:725–30.CrossRefPubMed
12.
Zurück zum Zitat Asbell PA, Sanfilippo CM, Sahm DF, DeCory HH. Trends in antibiotic resistance among ocular microorganisms in the United States from 2009 to 2019. JAMA Ophthalmol. 2020;138:439–50.CrossRefPubMed Asbell PA, Sanfilippo CM, Sahm DF, DeCory HH. Trends in antibiotic resistance among ocular microorganisms in the United States from 2009 to 2019. JAMA Ophthalmol. 2020;138:439–50.CrossRefPubMed
13.
Zurück zum Zitat Ueda K, Iwasaki T, Ono T, Lee J, Nejima R, Mori Y, et al. Age factor in the fluoroquinolone susceptibility of gram-positive cocci isolates from bacterial keratitis cases between 2008 and 2016. Graefes Arch Clin Exp Ophthalmol. 2021;259:3351–7.CrossRefPubMed Ueda K, Iwasaki T, Ono T, Lee J, Nejima R, Mori Y, et al. Age factor in the fluoroquinolone susceptibility of gram-positive cocci isolates from bacterial keratitis cases between 2008 and 2016. Graefes Arch Clin Exp Ophthalmol. 2021;259:3351–7.CrossRefPubMed
14.
Zurück zum Zitat Chalita MG, Höfling-Lima AN, Paranhos A Jr, Schor P, Belfort R Jr. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during period of 15 years. Am J Ophthalmol. 2004;137:43–51.CrossRefPubMed Chalita MG, Höfling-Lima AN, Paranhos A Jr, Schor P, Belfort R Jr. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during period of 15 years. Am J Ophthalmol. 2004;137:43–51.CrossRefPubMed
15.
Zurück zum Zitat Kurokawa N, Hayashi K, Konishi M, Yamada M, Noda T, Mashima Y. Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan. Jpn J Ophthalmol. 2002;46:586–9.CrossRefPubMed Kurokawa N, Hayashi K, Konishi M, Yamada M, Noda T, Mashima Y. Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan. Jpn J Ophthalmol. 2002;46:586–9.CrossRefPubMed
16.
Zurück zum Zitat Miyanaga M, Nejima R, Miyai T, Miyata K, Ohashi Y, Inoue Y, et al. Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones. J Cataract Refract Surg. 2009;35:1970–8.CrossRefPubMed Miyanaga M, Nejima R, Miyai T, Miyata K, Ohashi Y, Inoue Y, et al. Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones. J Cataract Refract Surg. 2009;35:1970–8.CrossRefPubMed
17.
Zurück zum Zitat Nejima R, Shimizu K, Ono T, Noguchi Y, Yagi A, Iwasaki T, et al. Effect of the administration period of perioperative topical levofloxacin on normal conjunctival bacterial flora. J Cataract Refract Surg. 2017;43:42–8.CrossRefPubMed Nejima R, Shimizu K, Ono T, Noguchi Y, Yagi A, Iwasaki T, et al. Effect of the administration period of perioperative topical levofloxacin on normal conjunctival bacterial flora. J Cataract Refract Surg. 2017;43:42–8.CrossRefPubMed
18.
Zurück zum Zitat Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolone. Br J Ophthalmol. 2008;92:848–51.CrossRefPubMed Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolone. Br J Ophthalmol. 2008;92:848–51.CrossRefPubMed
19.
Zurück zum Zitat Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 30th edition. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2020. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 30th edition. CLSI supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2020.
20.
Zurück zum Zitat Otto M, Echner H, Welter W, Götz F. Pheromone cross-inhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun. 2001;69:1957–60.CrossRefPubMedPubMedCentral Otto M, Echner H, Welter W, Götz F. Pheromone cross-inhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun. 2001;69:1957–60.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidis esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465:346–9.CrossRefPubMed Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidis esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465:346–9.CrossRefPubMed
22.
Zurück zum Zitat Aragona P, Baudouin C, Del Castillo JMB, Messmer E, Barabino S, Merayo-Lloves J, et al. The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. Surv Ophthalmol. 2021;66:907–25.CrossRefPubMed Aragona P, Baudouin C, Del Castillo JMB, Messmer E, Barabino S, Merayo-Lloves J, et al. The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. Surv Ophthalmol. 2021;66:907–25.CrossRefPubMed
23.
Zurück zum Zitat Omatsu H, Miyazaki D, Tominaga T, Matsuura K, Inoue Y. Bacterial flora in the conjunctival sac in eyes before cataract surgery cultured as routine procedure. Rinsho Ganka. 2014;68:637–43 (in Japanese). Omatsu H, Miyazaki D, Tominaga T, Matsuura K, Inoue Y. Bacterial flora in the conjunctival sac in eyes before cataract surgery cultured as routine procedure. Rinsho Ganka. 2014;68:637–43 (in Japanese).
24.
Zurück zum Zitat Sakisaka T, Iwasaki T, Ono T, Ueda K, Nejima R, Mori Y, et al. Changes in the preoperative ocular surface flora with an increase in patient age: a surveillance analysis of bacterial diversity and resistance to fluoroquinolone. Graefes Arch Clin Exp Ophthalmol. 2023;261:3231–9.CrossRefPubMed Sakisaka T, Iwasaki T, Ono T, Ueda K, Nejima R, Mori Y, et al. Changes in the preoperative ocular surface flora with an increase in patient age: a surveillance analysis of bacterial diversity and resistance to fluoroquinolone. Graefes Arch Clin Exp Ophthalmol. 2023;261:3231–9.CrossRefPubMed
Metadaten
Titel
Levofloxacin susceptibility of Staphylococci from conjunctiva in patients with atopic dermatitis
verfasst von
Yumi Kusumi
Yoshimasa Ando
Chika Shigeyasu
Masaki Fukui
Masakazu Yamada
Publikationsdatum
05.02.2024
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 2/2024
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-023-01046-y

Weitere Artikel der Ausgabe 2/2024

Japanese Journal of Ophthalmology 2/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.